To determine the cardiovascular implications during COVID-19 progression, the dynamic changes in heart rate, blood pressure, and 5 clinical laboratory parameters, including creatine kinase-MB, α-hydroxybutyric dehydrogenase, lactate dehydrogenase, cTnT, and NT-proBNP were tracked in survivors (Figs. 1 and 2). The gene discussed is TNNT2; the disease is COVID-19.